Increasing access to medicine for underserved populations.


For nearly a decade, Green Chemistry has been a hallmark of Bright Path Labs approach to chemical reactions and route design.  We have learned we can control the sustainability of a chemical process by focusing in early on the synthesis stage.  By proactively selecting the green reaction pathways, we can decrease the number of synthesis steps and chemical reagents needed, separations, protection group additions/removals, and purification stages. 


Also, by limiting solvent usage, or using more environmentally benign solvents, we can decrease or eliminate the need for extensive solvent removal steps, purification, and recycling, as well as the purchasing of the solvent. This not only leads to obvious advantages from a synthesis and process standpoint, but also brings significant cost and energy savings as well as worker safety benefits.

The premise of employing a Green Chemistry approach is to contribute to the development of sustainable manufacturing processes.   For pharmaceuticals, this means simplifying the reaction strategy, minimizing resources, lowering capital equipment needs and energy consumption, decreasing process manufacturing time and improving human health and environmental impacts throughout the product’s entire life cycle.  We are proud of our leadership in this area and the academic and lab accomplishments we’ve achieved.


Bright Path Labs multiple patents in connection with our STT® continuous-flow reactor, which technology allows Bright Path Labs to significantly decrease inefficiencies, reduce waste, lower risks, and do so as one of the few continuous flow purveyors of Green Chemistry and Green Manufacturing. The process also requires a reduced footprint therefore accelerating our ability to scale across academic sites or partnering labs without incurring large capital expenditures or environmental impact.